| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.43▲ | 4.48▼ | 4.48▼ | 4.70▼ | 4.69▼ |
| MA10 | 4.45▼ | 4.50▼ | 4.56▼ | 4.86▼ | 4.43▲ |
| MA20 | 4.47▼ | 4.58▼ | 4.69▼ | 4.78▼ | 4.57▼ |
| MA50 | 4.50▼ | 4.75▼ | 4.86▼ | 4.43▲ | 5.62▼ |
| MA100 | 4.60▼ | 4.88▼ | 4.87▼ | 4.71▼ | 6.75▼ |
| MA200 | 4.75▼ | 4.83▼ | 4.63▼ | 5.35▼ | 8.31▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.005▼ | -0.023▼ | -0.054▼ | 0.090▲ |
| RSI | 37.324▼ | 29.299▼ | 30.818▼ | 43.745▼ | 46.027▼ |
| STOCH | 20.434 | 16.218▼ | 8.618▼ | 26.450 | 63.844 |
| WILL %R | -78.947▼ | -94.366▼ | -95.122▼ | -97.970▼ | -57.101 |
| CCI | -43.478 | -122.032▼ | -109.261▼ | -218.881▼ | 28.716 |
|
Monday, November 03, 2025 05:07 AM
LOS ALTOS, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/11/25 | 4.74 | 4.74 | 4.415 | 4.435 | 789,950 |
| 31/10/25 | 4.82 | 4.83 | 4.63 | 4.75 | 423,500 |
| 30/10/25 | 4.83 | 5.065 | 4.765 | 4.81 | 523,200 |
| 29/10/25 | 4.81 | 5.09 | 4.725 | 4.80 | 935,800 |
| 28/10/25 | 5.23 | 5.31 | 4.62 | 4.72 | 1,720,736 |
| 27/10/25 | 5.23 | 5.40 | 5.10 | 5.24 | 332,400 |
| 24/10/25 | 4.93 | 5.15 | 4.93 | 5.13 | 417,000 |
| 23/10/25 | 4.88 | 5.02 | 4.86 | 4.86 | 125,200 |
| 22/10/25 | 4.94 | 5.16 | 4.78 | 4.89 | 406,700 |
| 21/10/25 | 5.00 | 5.08 | 4.86 | 4.94 | 236,000 |
|
|
||||
|
|
||||
|
|